p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling.
By A. Budanov, M. Karin. Cell, 2008
1,340 citations recorded by the source corpus.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/24547df20ab0ce061dfec91e3b73899e1e645e28
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- David M. Sabatini
- M. Laplante
- Michael N. Hall
- K. Guan
- Asier González González
- R. Shaw
- Roberto Zoncu
- Timothy R. Peterson
Citations in the corpus
- Mitochondria and Mitophagy: The Yin and Yang of Cell Death Control (2012, background): “Many products of these target genes, such as AMP-activated protein kinase, tuberous sclerosis protein 2, and sestrin1/2 converge on the mTOR pathway.(80,81) mTOR is a negative regulator of autophagy, and inhibition of this pathway results in the induction of autophagy.”
- Blinded by the Light: The Growing Complexity of p53. (2009, background): “to negatively regulate the kinase mTOR (mammalian target of rapamycin), a central node in the control of protein synthesis (Budanov and Karin, 2008; Feng et al., 2007a) (Figure 1).”
- LKB1 and AMPK control of mTOR signalling and growth (2009, background): “Recently, the critical transcriptional targets of p53 that mediate the suppression of mTORC1 were identified as Sestrin1 and Sestrin2 (Budanov & Karin 2008).”
- Targeting p53 pathways: mechanisms, structures and advances in therapy (2023, background): “The p53 target genes Sestrin1 and Sestrin2 phosphorylate and activate AMPK and promote autophagy.(178) p53 induces mitophagy by increasing the level of BNIP3.”
- Regulation of mTORC1 by amino acids (2014, neutral): “The TSC complex, whose loss underlies a hamartomatous syndrome of the same name (17, 18), serves as a central hub for numerous extracellular and intracellular inputs including mitogen and growth factor signaling (19-23), energy levels (24), oxygen availability (25, 26) and genotoxic stress (27), whi”
- Translational regulation of gene expression during conditions of cell stress. (2010, background): “Signaling to mTOR, and thus 4EBP1, upon DNA damage appears to occur through a p53-dependent pathway requiring transcriptional activation of Sestrin1 and Sestrin2, which in turn activate AMP-responsive protein kinase (AMPK), which then activates the repressor of mTOR TSC2 (Budanov and Karin, 2008).”
- Nutrient sensing and TOR signaling in yeast and mammals (2017, positive): “…proposed to repress mTORC1 through at least three different mechanisms: (i) by activating AMPK (AMP-activated protein kinase) and the TSC complex (Budanov & Karin, 2008), (ii) by acting as a GDI (guanosine dissociation inhibitor) to prevent GDP dissociation from RAGA/B (Peng et al , 2014), and…”
- The LKB1-AMPK pathway: metabolism and growth control in tumor suppression (2009, background): “43 , and this led to the discovery of sestrin 1 ( SESN1 ) and sestrin 2 ( SESN2 ) — p53 target genes that inhibit mTOR signallin”
- ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS (2010, background): “The p53-regulated genes Sestrin 1 and Sestrin 2 were shown to activate AMPK and repress mTORC1 signaling in response to camptothecin-induced genotoxic stress in a redoxindependent manner (21).”